Wednesday Feb 19
Pharmaceutical Executive, Rick Burch named President of Innovative Med Concepts, LLC
Prior to UCB, he had a 30-year career with pharmaceutical giant Pfizer, starting as a sales rep and working his way up to Senior Vice President overseeing several divisions as large as 6,500 people and in revenue.
Sun Feb 16, 2014
Pregabalin Effectively Treats Restless Leg Syndrome
A report in the February 13 issue of the New England Journal of Medicine confirms previous studies suggesting that long-term treatment with the type of drugs commonly prescribed for restless leg syndrome can cause a serious worsening of the condition in some patients.
Fri Feb 14, 2014
Pain Management Devices Market - Global Industry Analysis, Size,...
The global pain management therapeutics market is expected to witness a decline during the forecast period due to patent expirations of the key revenue generating drugs such as Cymbalta of Eli Lilly & Co.
Thu Feb 13, 2014
Pregabalin effectively treats restless leg syndrome with less risk of worsening symptoms
A report in the Feb. 13 New England Journal of Medicine confirms previous studies suggesting that long-term treatment with the type of drugs commonly prescribed to treat restless leg syndrome can cause a serious worsening of the condition in some patients.
Wed Feb 12, 2014
Lyrica Shows Promise in Restless Legs Syndrome
Some 700 adults with moderate-to-severe RLS were randomized to daily pregabalin or pramipexole for 52 weeks, or to placebo for 12 weeks followed by 40 weeks of one of the active treatments.
Fri Feb 07, 2014
Pfizer Inc. v. Teva Pharmaceuticals USA, Inc.
The standard of review at the Federal Circuit is important. Even though it often appears like cases are re-litigated at the Appeals Court, it is actually very difficult to overturn a lower court's factual determinations.